Trials / Unknown
UnknownNCT00954811
Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)
A Phase IV Study on the Effect of Luteal Supplementation With Rec-LH on the Pregnancy Rate After Ovulation Triggering With GnRH-agonist Instead of HCG in IVF Protocol;Proof of Concept
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Universitair Ziekenhuis Brussel · Academic / Other
- Sex
- Female
- Age
- 20 Years – 36 Years
- Healthy volunteers
- Not accepted
Summary
Our aim is to access whether we can achieve equivalent pregnancy rates by the addition of six doses of luteal support with recLH after agonist triggering for IVF cycles in the absence of OHSS.
Detailed description
Whether pregnancy outcome after GnRH-agonist triggering could be improved by adding luteal recLH support plus progesterone, compared to that observed after ovulation triggering with HCG in GnRH antagonist stimulated cycles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 300IU rec-LH | luteal alternate doses |
| DRUG | progesterone 600mg | luteal support |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2008-01-01
- Completion
- 2010-12-01
- First posted
- 2009-08-07
- Last updated
- 2010-01-08
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00954811. Inclusion in this directory is not an endorsement.